Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANGH | Anghami | $3.77 | $1.45 | 62.50% | 43.1M | $16M | $2.25$8.40 |
| ESHA | Esh Acquisition Corp. | $19.18 | $4.80 | 33.38% | 7.8M | $56M | $10.76$27.00 |
| AEI | Alset | $3.44 | $0.70 | 25.55% | 137.3K | $107M | $0.70$4.55 |
| VNDA | Vanda Pharmaceuticals | $8.82 | $1.79 | 25.46% | 23.8M | $415M | $3.81$9.60 |
| BYFC | Broadway Financial | $7.40 | $1.39 | 23.13% | 137.4K | $55M | $5.51$9.46 |
| AXSM | Axsome Therapeutics | $182.64 | $33.85 | 22.75% | 3.1M | $7.5B | $79.19$184.40 |
| LPCN | Lipocine | $8.03 | $1.46 | 22.22% | 421.9K | $36M | $2.52$8.29 |
| BENF | Beneficient | $7.03 | $1.27 | 22.05% | 216.6K | $81M | $1.75$12.48 |
| SNSE | Sensei Biotherapeutics | $10.67 | $1.82 | 20.61% | 117.3K | $11M | $5.00$18.35 |
| PARK | Park Dental Partners | $14.76 | $2.35 | 18.94% | 37.2K | $51M | $9.53$17.84 |
Related Articles
Featured Article
2 Under-the-Radar Stocks to Buy Heading Into 2026
Prosper Junior Bakiny|Dec 1, 2025
These drugmakers are poised to profit from their innovative engines.
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
Prosper Junior Bakiny|Sep 30, 2025
Both should have significant catalysts by the end of the decade.
Advertisement
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
1 Under-the-Radar Biotech Stock to Buy and Hold
Prosper Junior Bakiny|Sep 29, 2024
It could be an industry giant in the making.
Should You Buy This Sinking Stock on the Dip?
Prosper Junior Bakiny|Jun 27, 2024
The biotech isn't having the best year.
Prediction: These 2 Growth Stocks Could Triple By 2030
Prosper Junior Bakiny|May 11, 2024
These companies have a habit of silencing the bears.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Sushree Mohanty|Aug 24, 2023
Today's market loser could be tomorrow's market winner.
